Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Methods and rationale of the DISCOVER CKD global observational study.
Pecoits-Filho R, James G, Carrero JJ, Wittbrodt E, Fishbane S, Sultan AA, Heerspink HJL, Hedman K, Kanda E, Chen HT, Kashihara N, Sloand J, Kosiborod M, Kumar S, Lainscak M, Arnold M, Lam CSP, Holmqvist B, Pollock C, Fenici P, Stenvinkel P, Medin J, Wheeler DC. Pecoits-Filho R, et al. Among authors: medin j. Clin Kidney J. 2021 Apr 11;14(6):1570-1578. doi: 10.1093/ckj/sfab046. eCollection 2021 Jun. Clin Kidney J. 2021. PMID: 34249352 Free PMC article.
Characteristics, Symptom Severity, and Experiences of Patients Reporting Chronic Kidney Disease in the PatientsLikeMe Online Health Community: Retrospective and Qualitative Study.
James G, Nyman E, Fitz-Randolph M, Niklasson A, Hedman K, Hedberg J, Wittbrodt ET, Medin J, Moreno Quinn C, Allum AM, Emmas C. James G, et al. Among authors: medin j. J Med Internet Res. 2020 Jul 15;22(7):e18548. doi: 10.2196/18548. J Med Internet Res. 2020. PMID: 32673242 Free PMC article.
Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study.
Nicolucci A, Chen H, Cid-Ruzafa J, Cooper A, Fenici P, Gomes MB, Hammar N, Khunti K, Kosiborod M, Leigh P, Medin J, Rathmann W, Shestakova MV, Shimomura I, Siddiqui A, Tang F, Watada H, Ji L; DISCOVER investigators. Nicolucci A, et al. Among authors: medin j. Diabetes Res Clin Pract. 2021 Oct;180:108974. doi: 10.1016/j.diabres.2021.108974. Epub 2021 Jul 22. Diabetes Res Clin Pract. 2021. PMID: 34302913
Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER study.
Nicolucci A, Chen H, Cooper A, Fenici P, Gomes MB, Hammar N, Ji L, Khunti K, Kosiborod M, Medin J, Shestakova MV, Shimomura I, Tang F, Vora J, Watada H, Arnold SV; DISCOVER investigators. Nicolucci A, et al. Among authors: medin j. Diabetes Res Clin Pract. 2022 Mar;185:109218. doi: 10.1016/j.diabres.2022.109218. Epub 2022 Jan 31. Diabetes Res Clin Pract. 2022. PMID: 35114299
No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study.
Zivadinov R, Khan N, Korn JR, Lathi E, Silversteen J, Calkwood J, Kolodny S, Silva D, Medin J, Weinstock-Guttman B; MS-MRIUS study group. Zivadinov R, et al. Among authors: medin j. Curr Med Res Opin. 2018 Aug;34(8):1431-1440. doi: 10.1080/03007995.2018.1458708. Epub 2018 Apr 12. Curr Med Res Opin. 2018. PMID: 29648900
253 results